Roivant Sciences Officer Eric Venker Files Form 144 to Sell $7.3M in Common Shares

Executive Summary

On October 28, 2026, Eric Venker, an Officer at Roivant Sciences Ltd. (NASDAQ: ROIV), submitted a Form 144 notice disclosing an intention to sell 200,000 common shares with an estimated aggregate market value of $7,317,764.00 through broker Rockefeller Financial LLC.

Transaction Details

• Security: Common Shares
• Proposed Sale Quantity: 200,000 shares
• Aggregate Market Value: $7,317,764.00 (approx. $36.59 per share)
• Shares Outstanding: 722,323,015 shares (sale represents ~0.03% of shares outstanding)
• Approximate Sale Date: October 28, 2026
• Broker: Rockefeller Financial LLC

Origin of Securities

The shares slated for sale were acquired through option exercises and restricted stock unit (RSU) vesting:

• 145,801 shares acquired via Option Exercise on June 2, 2025 (grant date April 20, 2022)
• 14,023 shares acquired via Option Exercise on March 20, 2025 (grant date April 20, 2022)
• 40,176 shares total acquired via multiple RSU vestings between October 2023 and March 2025

Past 3-Month Activity & Trading Plan Context

The filing notes that sales are being conducted pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 30, 2026. The insider has maintained a systematic selling schedule under this plan:

• August 20, 2026: 13,909 shares for $512,407.56
• August 28, 2026: 200,000 shares for $7,147,087.91
• September 30, 2026: 200,000 shares for $7,323,556.00
• October 20, 2026: 200,000 shares for $7,023,513.39

Market & Significance Assessment

Trading significance is rated Medium. While the transaction value of $7.32M is sizeable, it represents a fractional percentage of total outstanding shares (~0.03%) and reflects planned, recurring monthly liquidation under an established Rule 10b5-1 trading schedule rather than spontaneous discretionary insider selling.